Circular RNA: Vaccines, therapeutics and biomarkers could be revolutionised [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
mRNA therapies and vaccines have revolutionised the drug development space in the last few years thanks to breakthroughs in advanced research. Now, only a few years after the first mRNA vaccine was authorised, the mRNA approach may soon be trumped by circular RNA (circRNA). CircRNA is a type of single-stranded RNA that, unlike linear RNA, forms a covalently closed continuous loop. In circular RNA, the 3' and 5' ends that are normally present in an RNA molecule are joined together. mRNA vaccines will be key in preventing and treating diseases in the future, but expensive manufacturing, requirements for cold-chain storage, and difficulties in transporting make their use complicated. In such circumstances, circRNA could step in and take its place. Alex Wesselhoeft, PhD, director of RNA Therapeutics at the Gene and Cell Therapy Institute, Mass General Brigham, says it is still early days with circRNA, but based on preclinical research, these candidates could be even better than mRN
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Harding Loevner Global Equity Composite Q1 2024 Report [Seeking Alpha]Seeking Alpha
- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Got $500? 3 Pharma Stocks to Buy and Hold Forever [Yahoo! Finance]Yahoo! Finance
- 3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow [Yahoo! Finance]Yahoo! Finance
- 2 Biotech Stocks to Buy in May [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 5/6/24 - Beat
VRTX
Sec Filings
- 5/28/24 - Form 144
- 5/24/24 - Form 4
- 5/24/24 - Form 144
- VRTX's page on the SEC website